Anti-CD38 monoclonal antibody
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Anti-CD38 monoclonal antibody, covering 2020-04-15 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) [Phase 2]